Savara (SVRA) Capital Expenditures (2010 - 2026)
Savara's (SVRA) quarterly Capital Expenditures came in at $54000.0 in Q1 2026, up 1700.0% year-on-year from $3000.0 in Q1 2025, and up 2600.0% on a QoQ basis from $2000.0 in Q4 2025.
Savara (SVRA) Capital Expenditures (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Capital Expenditures data on file, last reported at $54000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 1700.0% year-over-year to $54000.0 in Q1 2026; TTM through Mar 2026 was $73000.0, a 305.56% increase from a year earlier, with the FY2025 full-year figure at $22000.0, down 12.0% from the prior year.
- Capital Expenditures for Q1 2026 stood at $54000.0, up from $2000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for SVRA reached as high as $225000.0 in Q2 2023 and fell as low as -$9000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $28642.9 across 5 years, with a median of $7000.0 in 2022.
- Across the five-year window, Capital Expenditures slumped 137.5% in 2024 and soared 1700.0% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at $4000.0 in 2022, then surged by 500.0% to $24000.0 in 2023, then slumped by 137.5% to -$9000.0 in 2024, then surged by 122.22% to $2000.0 in 2025, then jumped by 2600.0% to $54000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $54000.0 in Q1 2026, $2000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 54,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Dec 31, 2023 | 24,000.00 |